Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Taiko Pharmaceutical CoTSE:4574 +3.37%64 Dividend Payout Ratio is 0.80 as of Dec. 2025, which is 281% above its 10-year median of 0.21. GuruFocus rates TSE:4574 with a GF Score™ of 64/100 and a GF Value™ of 円352.09 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 445 Drug Manufacturers companies, Taiko Pharmaceutical Co ranks worse than 84.04% on this metric.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Taiko Pharmaceutical Co's Dividend Payout Ratio for the
months ended in Dec. 2025 was 0.80.
Warning Sign:
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Taiko Pharmaceutical Co Ltd is 0.79, which seems too high.
The historical rank and industry rank for Taiko Pharmaceutical Co's Dividend Payout Ratio or its related term are showing as below:
TSE:4574'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.17 Med: 0.21 Max: 0.79
Current: 0.79
During the past 13 years, the highest Dividend Payout Ratio of Taiko Pharmaceutical Co was 0.79. The lowest was 0.17. And the median was 0.21.
TSE:4574's Dividend Payout Ratio is ranked worse than 84.04% of 445
companies
in the Drug Manufacturers industry
Industry Median: 0.38
vs TSE:4574: 0.79
During the past 13 years, the highest Trailing Annual Dividend Yield of Taiko Pharmaceutical Co was 1.45%. The lowest was 0.35%. And the median was 0.80%.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Taiko Pharmaceutical Co was 81.70% per year. The lowest was 0.00% per year. And the median was 18.60% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Taiko Pharmaceutical Co (TSE:4574) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Taiko Pharmaceutical Co Dividend Payout Ratio Related Terms
Taiko Pharmaceutical Co Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for Taiko Pharmaceutical Co's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Taiko Pharmaceutical Co Dividend Payout Ratio Chart
TSE:4574 vs ZTS, UTHR: Dividend Payout Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Taiko Pharmaceutical Co's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Taiko Pharmaceutical Co Dividend Payout Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Taiko Pharmaceutical Co's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Taiko Pharmaceutical Co's Dividend Payout Ratio falls into.
Taiko Pharmaceutical Co Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
Taiko Pharmaceutical Co's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Taiko Pharmaceutical Co (TSE:4574) has a Dividend Payout Ratio of 0.80 as of Dec. 2025. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Taiko Pharmaceutical Co and its competitors. This is 281% above median its historical median of 0.21. Over the past decade, Taiko Pharmaceutical Co's Dividend Payout Ratio has ranged from 0.17 to 0.79. According to the industry distribution chart, Taiko Pharmaceutical Co ranks #374 out of 445 companies in the Drug Manufacturers industry, placing it in the top 84%.
Is Taiko Pharmaceutical Co's Dividend Payout Ratio too high?
Taiko Pharmaceutical Co's current Dividend Payout Ratio of 0.80 is 281% above median its 10-year median of 0.21. Over the past 10 years, this metric has ranged from a low of 0.17 to a high of 0.79. The Drug Manufacturers industry median Dividend Payout Ratio is 0.38. Taiko Pharmaceutical Co's value of 0.80 is 110.5% above this industry median. Based on the distribution chart, Taiko Pharmaceutical Co ranks #374 out of 445 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Taiko Pharmaceutical Co has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Taiko Pharmaceutical Co's Dividend Payout Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Taiko Pharmaceutical Co ranks #374 out of 445 companies for Dividend Payout Ratio. This places Taiko Pharmaceutical Co in the lower half of its industry. The industry median Dividend Payout Ratio is 0.38. Taiko Pharmaceutical Co's value of 0.80 is 110.5% above this benchmark. Historically, Taiko Pharmaceutical Co's own Dividend Payout Ratio has ranged from 0.17 to 0.79 over the past decade. While the company's 10-year median is 0.21 vs. the industry median of 0.38, Taiko Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 445 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Taiko Pharmaceutical Co's current Dividend Payout Ratio of 0.80 is 110.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Taiko Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Taiko Pharmaceutical Co's current Dividend Payout Ratio is 0.80, which is 281% above median its own 10-year median of 0.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Taiko Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Taiko Pharmaceutical Co (TSE:4574) is currently considered Modestly Undervalued. The stock's GF Value™ is 円352.09, compared to a current price of 円276.00 — trading 21.6% below its estimated fair value. The current Dividend Payout Ratio is 0.80, which is 281% above median its 10-year median of 0.21 and 110.5% above the Drug Manufacturers industry median of 0.38. Taiko Pharmaceutical Co's overall GF Score™ is 64/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Taiko Pharmaceutical Co (TSE:4574), the current Dividend Payout Ratio is 0.80 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Taiko Pharmaceutical Co (TSE:4574) Overvalued in 2026?
Based on GuruFocus' analysis, Taiko Pharmaceutical Co stock appears to be undervalued.
The current stock price of 円276.00 is trading 21.6% below its estimated GF Value™ of 円352.09.
GuruFocus considers Taiko Pharmaceutical Co to be Modestly Undervalued.
Key valuation signals for TSE:4574:
Dividend Payout Ratio: 0.80 (281% above median its 10-year median of 0.21)
GF Value™: 円352.09 vs. price of 円276.00 (21.6% below fair value)
Industry Position: 110.5% above the Drug Manufacturers median (#374 of 445)
No single metric tells the full story. See the TSE:4574 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Taiko Pharmaceutical Co Ltd operates in three segments, namely Pharmaceutical, Infection Control, and Others. The majority of its revenue comes from Infection Control, which is into manufacturing and sales of sanitation control products, including Cleverin, Cleverin LED, and Cleverin Generator LISPASS. The pharmaceutical segment is into the manufacturing and sales of OTC medicines and designated quasi-drugs. Other business includes manufacturing and sales of wood vinegar-based products.
64GF Score
Get the complete analysis for TSE:4574
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4574 has been successfully added to your 
